HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $50.00
Neurogene (NASDAQ:NGNE – Get Free Report) had its price target cut by analysts at HC Wainwright from $55.00 to $50.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 209.79% from the […]
More Stories
Thrivent Financial for Lutherans Trims Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT)
Thrivent Financial for Lutherans reduced its stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 48.0% in the fourth...
Thrivent Financial for Lutherans Trims Position in Veris Residential, Inc. (NYSE:VRE)
Thrivent Financial for Lutherans lowered its holdings in Veris Residential, Inc. (NYSE:VRE – Free Report) by 1.5% in the fourth...
Viking (VIK) versus Its Peers Head-To-Head Analysis
Viking (NYSE:VIK – Get Free Report) is one of 30 public companies in the “Water transportation” industry, but how does...
Thrivent Financial for Lutherans Increases Stock Position in Ormat Technologies, Inc. (NYSE:ORA)
Thrivent Financial for Lutherans raised its stake in Ormat Technologies, Inc. (NYSE:ORA – Free Report) by 6.9% in the 4th...
Commonwealth Equity Services LLC Cuts Stock Holdings in Patterson Companies, Inc. (NASDAQ:PDCO)
Commonwealth Equity Services LLC lowered its stake in shares of Patterson Companies, Inc. (NASDAQ:PDCO – Free Report) by 4.4% in...
Thrivent Financial for Lutherans Grows Stake in Columbia EM Core ex-China ETF (NYSEARCA:XCEM)
Thrivent Financial for Lutherans lifted its holdings in shares of Columbia EM Core ex-China ETF (NYSEARCA:XCEM – Free Report) by...